Skip to main content

Main menu

  • Home
  • Current Issue
  • Content
    • Current Issue
    • Early Access
    • Multimedia
    • Podcast
    • Collections
    • Past Issues
    • Articles by Subject
    • Articles by Type
    • Supplements
    • Plain Language Summaries
    • Calls for Papers
  • Info for
    • Authors
    • Reviewers
    • Job Seekers
    • Media
  • About
    • Annals of Family Medicine
    • Editorial Staff & Boards
    • Sponsoring Organizations
    • Copyrights & Permissions
    • Announcements
  • Engage
    • Engage
    • e-Letters (Comments)
    • Subscribe
    • Podcast
    • E-mail Alerts
    • Journal Club
    • RSS
    • Annals Forum (Archive)
  • Contact
    • Contact Us
  • Careers

User menu

  • My alerts

Search

  • Advanced search
Annals of Family Medicine
  • My alerts
Annals of Family Medicine

Advanced Search

  • Home
  • Current Issue
  • Content
    • Current Issue
    • Early Access
    • Multimedia
    • Podcast
    • Collections
    • Past Issues
    • Articles by Subject
    • Articles by Type
    • Supplements
    • Plain Language Summaries
    • Calls for Papers
  • Info for
    • Authors
    • Reviewers
    • Job Seekers
    • Media
  • About
    • Annals of Family Medicine
    • Editorial Staff & Boards
    • Sponsoring Organizations
    • Copyrights & Permissions
    • Announcements
  • Engage
    • Engage
    • e-Letters (Comments)
    • Subscribe
    • Podcast
    • E-mail Alerts
    • Journal Club
    • RSS
    • Annals Forum (Archive)
  • Contact
    • Contact Us
  • Careers
  • Follow annalsfm on Twitter
  • Visit annalsfm on Facebook
Research ArticleOriginal ResearchA

Perceived Vulnerability to Heart Disease in Patients with Familial Hypercholesterolemia: A Qualitative Interview Study

Jan C. Frich, Leiv Ose, Kirsti Malterud and Per Fugelli
The Annals of Family Medicine May 2006, 4 (3) 198-204; DOI: https://doi.org/10.1370/afm.529
Jan C. Frich
MD, MSc
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Leiv Ose
MD, PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kirsti Malterud
MD, PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Per Fugelli
MD, PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • eLetters
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Tables

  • Additional Files
    • View popup
    Table 1.

    Characteristics of Participants (N = 40)

    CharacteristicNo. (%)
    Age, years
        10–199 (22.5)
        20–2910 (25.0)
        30–399 (22.5)
        40–498 (20.0)
        50 +4 (10.0)
    Sex
        Male20 (50.0)
        Female20 (50.0)
    Use of lipid-lowering medication35 (88.0)
    Symptoms of coronary heart disease7 (18.0)
    Children
        No21 (52.5)
        Yes19 (47.5)
    Occupation
        Professional or higher managerial7 (17.5)
        Other nonmanual7 (17.5)
        Skilled manual4 (10.0)
        Manual7 (17.5)
        Student, secondary education14 (23.0)
        Disablement benefit1 (0.0)
    • View popup
    Table 2.

    Interview Schedule

    Understanding of health and disease
    What does the word “health” mean to you?
    How do people stay healthy?
    Why do some people have better health than others?
    Are people able to control their own health?
    What is your image of the person who is at risk of heart disease?
    What does fate mean to you?
    Do you have a religious perspective on issues related to health and disease?
    The condition
    How did you get this condition and how was it diagnosed?
    Do you have any symptoms, ailments, pains, of anything that limits your daily activities?
    What influences how your condition will develop?
    How will this condition influence your own future health?
    To what extent are you able to influence how it develops?
    Understanding of risk, own vulnerability to disease
    What are the risks/uncertainties connected with your condition?
    How do you estimate your own vulnerability of developing coronary heart disease?
    Has the way you think about your own vulnerability to heart disease changed?
    What does the risk mean for you personally?
    What can you do to influence your risks?
    Do you make any efforts at reducing your risk?
    Experiences with the health service
    How has your contact with the health service been?
    How can health professionals help you manage your condition?
    What do you think about the information you have been given?
    Can health professional influence how you perceive your risk?
    The psychosocial context
    Has the condition influenced your quality of life?
    Have you talked with people outside your family about your condition?
    Can you give any examples of issues you would talk about?
    How do your family and friends manage your condition?
    How do you think other people perceive your condition (health professionals, friends, family, people in general)?
    Sources of knowledge, media
    What do you think about how your condition is portrayed in the media?
    In what way does information in the media influence how you understand your condition?
    Do you seek knowledge through other sources?

Additional Files

  • Tables
  • The Article in Brief

    Perceived Vulnerability to Heart Disease in Patients With Familial Hypercholesterolemia: A Qualitative Interview Study

    Jan C. Frich, MD, MSc, and colleagues

    Background Patients' perceptions of how likely they are to get a disease in the future can influence their attitudes toward medical treatment and preventive health measures. This study explores how patients with familial hypercholesterolemia (an inherited condition that causes high cholesterol) view their risk of getting coronary heart disease, which commonly results from the condition.

    What This Study Found In this study of 40 patients, family health history influences the ways in which participants' perceive their genetic and inherited risk of coronary heart disease, and the age at which they expect to develop symptoms. They compare themselves with other family members, focusing on sex, cholesterol levels, use of cholesterol-lowering medication, and lifestyle. Experiences such as cardiac illness in the family, other illness experiences, or becoming a parent cause a shift in some participants' sense of vulnerability to heart disease.

    Implications

    • Among people with familial hypercholesterolemia, unique life experiences and social factors help shape a sense of risk of developing coronary heart disease.
    • Knowing how patients understand their family health history and risk of disease can help doctors (1) understand patients' level of readiness for preventive medical care, and (2) tailor medical care to patients' individual needs.
  • Annals Journal Club Selections:

    May/June 2006

    The Annals Journal Club is designed to encourage a learning community of those seeking to improve health care and health through enhanced primary care. Additional information is available on the Journal Club home page.

    Articles for Discussion

    • Frich JC, Ose L, Malterud K, Fugelli P. Perceived vulnerability to heart disease in patients with familial hypercholesterolemia: a qualitative interview study. Ann Fam Med. 2006;4:198-204.
    • Goldman RE, Parker D, Eaton C, et al. Patients' perceptions of cholesterol, cardiovascular disease risk, and risk communication strategies. Ann Fam Med. 2006;4:205-212.

    Discussion Tips

    Both journal club articles in this issue are qualitative research studies. Qualitative research involves methods that are particularly strong for discerning meaning and context from the perspective of the study group. Weaknesses of qualitative methods often relate to the degree of transparency of the analysis, the sampling of participants, and the transportability of the findings to other settings.1

    Discussion Questions

    1. Why is an understanding of patients� risk perception important?
    2. What are the strengths and weaknesses of the focus group study design (Goldman) versus the use of depth interviews (Frich)? How might the findings be different if the study questions were asked by surveys? What biases are apparent in the way the data were collected?
    3. How transparent does the analysis appear for both studies? Would the results be as trustworthy if the analyses were conducted by an individual rather than a team?
    4. How does the way the participants were selected affect your interpretation of the findings?
    5. In qualitative research, the term �saturation� is used to indicate that a sufficient sample has been achieved such that new participants contribute relatively little new information. Do these studies� claims of having reached saturation convince you that the important domains of information have been uncovered?
    6. What are the main findings of each study? How do the two studies inform each other?
    7. How transportable are the findings to other settings (particularly to yours)?
    8. What are the studies� implications for how clinicians should talk (or listen) to patients regarding risk and risk perception?
    9. With the much-vaunted advent of �personalized medicine�2,3 based on genetic information, how will patients and clinicians reach a shared understanding of familial risk and personal vulnerability to heritable illness? How can the studies' findings help clinicians and patients communicate about inherited disease risk?
    10. What do these studies say about the whole idea of (genomically) �personalized medicine� and how it might or might not be feasible and ethical in practice?
    11. What are the implications for training clinicians and educating patients?
    12. What are the policy implications of these findings, eg for reimbursement for primary care visits?
    13. To explore the HeartAge calculator, visit www.heartage.com.

    References

    1. Crabtree BF, Miller WL, eds. Doing Qualitative Research. 2nd ed. Newbury Park, California: Sage Publications; 1999.
    2. Snyderman R, Langheier J. Prospective health care: the second transformation of medicine. Genome Biol. 2006;7:104. Epub 2006 Feb 27.
    3. Langreth R, Waldholz M. New era of personalized medicine: targeting drugs for each unique genetic profile. Oncologist. 1999;4:426-427.
PreviousNext
Back to top

In this issue

The Annals of Family Medicine: 4 (3)
The Annals of Family Medicine: 4 (3)
Vol. 4, Issue 3
1 May 2006
  • Table of Contents
  • Index by author
  • In Brief
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Annals of Family Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Perceived Vulnerability to Heart Disease in Patients with Familial Hypercholesterolemia: A Qualitative Interview Study
(Your Name) has sent you a message from Annals of Family Medicine
(Your Name) thought you would like to see the Annals of Family Medicine web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
10 + 7 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Perceived Vulnerability to Heart Disease in Patients with Familial Hypercholesterolemia: A Qualitative Interview Study
Jan C. Frich, Leiv Ose, Kirsti Malterud, Per Fugelli
The Annals of Family Medicine May 2006, 4 (3) 198-204; DOI: 10.1370/afm.529

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Get Permissions
Share
Perceived Vulnerability to Heart Disease in Patients with Familial Hypercholesterolemia: A Qualitative Interview Study
Jan C. Frich, Leiv Ose, Kirsti Malterud, Per Fugelli
The Annals of Family Medicine May 2006, 4 (3) 198-204; DOI: 10.1370/afm.529
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • INTRODUCTION
    • METHODS
    • RESULTS
    • DISCUSSION
    • Footnotes
    • REFERENCES
  • Figures & Data
  • eLetters
  • Info & Metrics
  • PDF

Related Articles

  • PubMed
  • Google Scholar

Cited By...

  • Enablers and barriers to treatment adherence in heterozygous familial hypercholesterolaemia: a qualitative evidence synthesis
  • The Agenda for Familial Hypercholesterolemia: A Scientific Statement From the American Heart Association
  • Patients Prefer Pictures to Numbers to Express Cardiovascular Benefit From Treatment
  • In This Issue: Communication in the Era of 'Personalized' Medicine
  • Annals Journal Club: A RADICAL Approach
  • Google Scholar

More in this TOC Section

  • Performance-Based Reimbursement, Illegitimate Tasks, Moral Distress, and Quality Care in Primary Care: A Mediation Model of Longitudinal Data
  • Adverse Outcomes Associated With Inhaled Corticosteroid Use in Individuals With Chronic Obstructive Pulmonary Disease
  • Family-Based Interventions to Promote Weight Management in Adults: Results From a Cluster Randomized Controlled Trial in India
Show more Original Research

Similar Articles

Subjects

  • Domains of illness & health:
    • Chronic illness
  • Person groups:
    • Family
  • Methods:
    • Qualitative methods
  • Other topics:
    • Patient perspectives
    • Social / cultural context

Content

  • Current Issue
  • Past Issues
  • Early Access
  • Plain-Language Summaries
  • Multimedia
  • Podcast
  • Articles by Type
  • Articles by Subject
  • Supplements
  • Calls for Papers

Info for

  • Authors
  • Reviewers
  • Job Seekers
  • Media

Engage

  • E-mail Alerts
  • e-Letters (Comments)
  • RSS
  • Journal Club
  • Submit a Manuscript
  • Subscribe
  • Family Medicine Careers

About

  • About Us
  • Editorial Board & Staff
  • Sponsoring Organizations
  • Copyrights & Permissions
  • Contact Us
  • eLetter/Comments Policy

© 2025 Annals of Family Medicine